Literature DB >> 27757500

[Association of HPV infection, p16 status, and efficacy of radiotherapy with or without cetuximab in advanced oropharyngeal squamous cell carcinoma].

Carsten Nieder1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27757500     DOI： 10.1007/s00066-016-1062-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

1.  Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.

Authors:  David I Rosenthal; Paul M Harari; Jordi Giralt; Diana Bell; David Raben; Joyce Liu; Jeltje Schulten; Kian K Ang; James A Bonner
Journal:  J Clin Oncol       Date:  2015-12-28       Impact factor: 44.544

2.  Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.

Authors:  Björn Zackrisson; Elisabeth Kjellén; Karin Söderström; Eva Brun; Jan Nyman; Signe Friesland; Johan Reizenstein; Helena Sjödin; Lars Ekberg; Britta Lödén; Lars Franzén; Anders Ask; Gun Wickart-Johansson; Freddi Lewin; Thomas Björk-Eriksson; Erik Lundin; Tina Dalianis; Johan Wennerberg; Karl-Axel Johansson; Per Nilsson
Journal:  Radiother Oncol       Date:  2015-09-29       Impact factor: 6.280

3.  Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival.

Authors:  H Mellin; S Friesland; R Lewensohn; T Dalianis; E Munck-Wikland
Journal:  Int J Cancer       Date:  2000-05-20       Impact factor: 7.396

4.  De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials.

Authors:  Liam Masterson; Daniel Moualed; Zi Wei Liu; James E F Howard; Raghav C Dwivedi; James R Tysome; Richard Benson; Jane C Sterling; Holger Sudhoff; Piyush Jani; Peter K C Goon
Journal:  Eur J Cancer       Date:  2014-08-01       Impact factor: 9.162

5.  Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: The Dana Farber Experience.

Authors:  Jochen H Lorch; Glenn J Hanna; Marshall R Posner; Anne O'Neill; Vijaya L Thotakura; Sewanti A Limaye; Guilherme Rabinowits; David J Sher; Roy B Tishler; Robert I Haddad
Journal:  Head Neck       Date:  2015-11-28       Impact factor: 3.147

6.  Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.

Authors:  James A Bonner; Paul M Harari; Jordi Giralt; Roger B Cohen; Christopher U Jones; Ranjan K Sur; David Raben; Jose Baselga; Sharon A Spencer; Junming Zhu; Hagop Youssoufian; Eric K Rowinsky; K Kian Ang
Journal:  Lancet Oncol       Date:  2009-11-10       Impact factor: 41.316
  6 in total
  1 in total

1.  Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.

Authors:  Yonca Onbasi; Sebastian Lettmaier; Markus Hecht; Sabine Semrau; Heinrich Iro; Marco Kesting; Rainer Fietkau; Marlen Haderlein
Journal:  Strahlenther Onkol       Date:  2019-01-04       Impact factor: 3.621
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.